Literature DB >> 28457656

Stimulating Patient Engagement in Medical Device Development in Kidney Disease: A Report of a Kidney Health Initiative Workshop.

Frank P Hurst1, Dolph Chianchiano2, Linda Upchurch3, Benjamin R Fisher4, Jennifer E Flythe5, Celeste Castillo Lee6, Terri Hill7, Carolyn Y Neuland4.   

Abstract

New technologies challenge current dialysis treatment paradigms as devices become smaller, more portable, and increasingly used outside the dialysis clinic. It is unclear how patients will view this care transition, and it will be important to consider patient and care partner perspectives during all aspects of development for novel dialysis therapies, from design and clinical trials to regulatory approval. To gain insight into this area, the Kidney Health Initiative, a public-private partnership between the American Society of Nephrology, the US Food and Drug Administration, and nearly 80 member organizations and companies dedicated to enhancing patient safety and fostering innovation in kidney disease, convened a workshop of patients, care partners, and other kidney community stakeholders. The workshop included background presentations followed by focused small group discussions in 3 areas (device design, clinical trials, and regulatory approval). Participants explored how to involve patients throughout the life cycle of a medical device, including discussions of how patients can influence device design, assist in the planning and implementation of clinical trials, and provide input to affect regulatory decisions. Patients were engaged in the workshop discussion and interested in sharing their perspectives, but they recommended additional efforts around education, communication, and outreach in these areas. Published by Elsevier Inc.

Entities:  

Keywords:  End-stage renal disease (ESRD); chronic kidney disease (CKD); dialysis; medical device; patient choice; patient engagement; patient experience; patient preference; patient satisfaction; patient-centered care; product development; renal failure; technological innovation; workshop

Mesh:

Year:  2017        PMID: 28457656      PMCID: PMC5610919          DOI: 10.1053/j.ajkd.2017.03.013

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

Review 1.  Randomized controlled trials in nephrology: state of the evidence and critiquing the evidence.

Authors:  Joshua A Samuels; Donald A Molony
Journal:  Adv Chronic Kidney Dis       Date:  2012-01       Impact factor: 3.620

2.  Engaging Patients Across the Spectrum of Medical Product Development: View From the US Food and Drug Administration.

Authors:  Nina L Hunter; Kathryn M O'Callaghan; Robert M Califf
Journal:  JAMA       Date:  2015-12-15       Impact factor: 56.272

3.  More than a kidney disease: a patient-centred approach to improving care in autosomal dominant polycystic kidney disease.

Authors:  Sajeda Youssouf; Tess Harris; Donal O'Donoghue
Journal:  Nephrol Dial Transplant       Date:  2015-03-13       Impact factor: 5.992

Review 4.  US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Yi Li; Bruce Robinson; Kevin C Abbott; Lawrence Y C Agodoa; John Ayanian; Jennifer Bragg-Gresham; Rajesh Balkrishnan; Joline L T Chen; Elizabeth Cope; Paul W Eggers; Daniel Gillen; Debbie Gipson; Susan M Hailpern; Yoshio N Hall; Kevin He; William Herman; Michael Heung; Richard A Hirth; David Hutton; Steven J Jacobsen; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Yee Lu; Miklos Z Molnar; Hal Morgenstern; Brahmajee Nallamothu; Danh V Nguyen; Ann M O'Hare; Brett Plattner; Ronald Pisoni; Friedrich K Port; Panduranga Rao; Connie M Rhee; Ankit Sakhuja; Douglas E Schaubel; David T Selewski; Vahakn Shahinian; John J Sim; Peter Song; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Sarah White; Kenneth Woodside; Richard A Hirth
Journal:  Am J Kidney Dis       Date:  2016-03       Impact factor: 8.860

Review 5.  The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov.

Authors:  Jula K Inrig; Robert M Califf; Asba Tasneem; Radha K Vegunta; Christopher Molina; John W Stanifer; Karen Chiswell; Uptal D Patel
Journal:  Am J Kidney Dis       Date:  2013-12-06       Impact factor: 8.860

6.  Fostering innovation, advancing patient safety: the kidney health initiative.

Authors:  Patrick Archdeacon; Rachel N Shaffer; Wolfgang C Winkelmayer; Ronald J Falk; Prabir Roy-Chaudhury
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 8.237

7.  Incorporating patient-preference evidence into regulatory decision making.

Authors:  Martin P Ho; Juan Marcos Gonzalez; Herbert P Lerner; Carolyn Y Neuland; Joyce M Whang; Michelle McMurry-Heath; A Brett Hauber; Telba Irony
Journal:  Surg Endosc       Date:  2015-01-01       Impact factor: 4.584

8.  Self-assessed physical and mental function of haemodialysis patients.

Authors:  S K Mittal; L Ahern; E Flaster; J K Maesaka; S Fishbane
Journal:  Nephrol Dial Transplant       Date:  2001-07       Impact factor: 5.992

9.  Barriers and strategies for recruiting study participants in clinical settings.

Authors:  Susan Sullivan-Bolyai; Carol Bova; Janet A Deatrick; Kathy Knafl; Margaret Grey; Katherine Leung; Allison Trudeau
Journal:  West J Nurs Res       Date:  2007-06       Impact factor: 1.967

10.  How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration.

Authors:  Pat Furlong; John F P Bridges; Lawrence Charnas; Justin R Fallon; Ryan Fischer; Kevin M Flanigan; Timothy R Franson; Neera Gulati; Craig McDonald; Holly Peay; H Lee Sweeney
Journal:  Orphanet J Rare Dis       Date:  2015-06-24       Impact factor: 4.123

  10 in total
  6 in total

1.  How Community Engagement Is Enhancing NIDDK Research.

Authors:  Paul L Kimmel; Nichole Jefferson; Jenna M Norton; Robert A Star
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-27       Impact factor: 8.237

2.  A Technology Roadmap for Innovative Approaches to Kidney Replacement Therapies: A Catalyst for Change.

Authors:  Joseph V Bonventre; Frank P Hurst; Melissa West; Iwen Wu; Prabir Roy-Chaudhury; Murray Sheldon
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-27       Impact factor: 8.237

Review 3.  Patient-centred clinical trial design.

Authors:  Allison Tong; Nicole Scholes-Robertson; Carmel Hawley; Andrea K Viecelli; Simon A Carter; Adeera Levin; Brenda R Hemmelgarn; Tess Harris; Jonathan C Craig
Journal:  Nat Rev Nephrol       Date:  2022-06-06       Impact factor: 42.439

4.  Conceptual Framework for Patient-Reported Outcome Measures in Clinical Trials of Skeletal Muscle Cramping Experienced in Dialysis: A Kidney Health Initiative Workgroup Report.

Authors:  Michelle M Richardson; Amanda Grandinetti; Tandrea S Hilliard-Boone; Kenneth R Wilund; Rebecca Wingard; Wendy L St Peter; Dilani Logan; Francesca Tentori; San Keller; Melissa West; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-15       Impact factor: 10.614

5.  Integrating Patient Perspectives into Medical Device Regulatory Decision Making to Advance Innovation in Kidney Disease.

Authors:  Michelle E Tarver; Carolyn Neuland
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-03       Impact factor: 8.237

6.  Medical Device Development Process, and Associated Risks and Legislative Aspects-Systematic Review.

Authors:  Petra Marešová; Blanka Klímová; Jan Honegr; Kamil Kuča; Wan Nur Hidayah Ibrahim; Ali Selamat
Journal:  Front Public Health       Date:  2020-07-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.